http://www.pdb.bnl.gov/, May 1994. |
H.J. Bohn, "The Computer Program LUDI: A New Method For The De Novo Design Of Enzyme Inhibitors", Journal of Computer-Aided Molecular Design, 6, pp. 61-78 (1992). |
C. Hansch et al., "Comparison of the Inhibition of Escherichia coli and Lactobacillus Casei Dihydrofolate Reductase by 2,4-diamino-5-(substituted-benzyl) pyrimidines: quantitative Stucture-Activity Relationships, X-Ray Crystallography and Computer Graphics in Structure-Activity Analysis", Chemical Abstracts, 97:298f, p. 29 (1982); Journal of Medicinal Chemistry, 25, pp. 777-784 (1982). |
R. Li, et al, "A Comparison by QSAR Crystallography and Computer Graphics of the Inhibition of Various Dihydrofolate Reductases by 5-(x-benzyl)-2,4-diaminopyrimidines", Chemical Abstracts, 98:17257a, p. 28 (1983); Quantitative Structure Activity Relationships Pharmacol. Chem. Biol., 1, pp. 1-7 (1982). |
Y.C. Martin, "3D Database Searching in Drug Design", Journal of Medicinal Chemistry, 35 (12), pp. 2145-2154, (Jun. 12, 1992). |
J.B. Moon et al., "Computer Design of Bioactive Molecules: A Method for Receptor-Based De Novo Ligand Design", Proteins, Structure, Functions and Genetics, 11, pp. 314-328 (1991). |
M.D. Sintchak et a., "Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic Acid", Cell, 85, pp. 921-930 (Jun. 14, 1996). |
P.N. Bryan, "Protein Engineering", Biotech Adv., 5, pp. 221-234 (1987). |
I.D. Campbell et al., "Diffraction in Biological Spectroscopy", The Benjamin/Cummings Publishing Company, Inc., Menlo Park, CA, pp. 299-326 (1984). |
J.A. Huete-Perez et al., "Identification of the IMP Binding Site in the IMP Dehydrogenase From Tritrichomonas Foetus", Biochemistry, 34, pp. 13889-13894 (Oct., 1995). |
C.R. Gregory et al., "Treatment With Rapamycin and Mycophenolic Acid Reduces Arterial Intimal Thickening Produced by Mechanical Injury and Allows Endothelial Replacement", Transplantation, 59(5), pp. 655-661 (Mar., 1995). |
J. Jancarik et al., "Sparse Matrix Sampling: A Screening Method for Crystallization of Proteins", J. Appl. Cryst., 24, pp. 409-411 (1991). |
A. Kajihara et al., "Protein Modelling Using a Chimera Reference Protein Derived From Exons", Protein Eng'g, 6, pp. 615-620 (1993). |
G.M. Makara et al., "Nuclear Magnetic Resonance and Molecular Modeling Study on Mycophenolic Acid: Implications for Binding to Inosine Monophosphate Dehydrogenase", J. Med. Chem., 39, pp. 1236-1242 (Mar., 1996). |
C. Montero et al., "Demonstration of Induction of Erythrocyte Inosine Monophosphate Dehydrogenase Activity in Ribavirin-Treated Patients Using a High Performance Liquid Chromatography Linked Method", Clinica Chimica Acta, 238, pp. 169-178 (Aug., 1995). |
R.E. Morris, "New Small Molecule Immunosuppressants for Transplantation: Review of Essential Concepts", The Journal of Heart and Lung Transplantation, 12, pp. S275-S286 (1993). |
D. Musil et al., "The Refined 2.15 .ANG. X-Ray Crystal Structure of Human Liver Cathepsin B: the Structural Basis for its Specificity", EMBO J., 10(9), pp. 2321-2330 (1991). |
A.J. Russell et al., "Rational Modification of Enzyme Catalysis by Engineering Surface Charge", Nature, 328, pp. 496-500 (1987). |
A.R. Sielecki et al., "Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 .ANG. Resolution", Science, 243, pp. 1346-1351 (1989). |
U. Uhlin et al., "Crystallization and Crystallographic Investigations of Ribonucleotide Reductase Protein R1 From Escherichia Coli", 336(1), pp. 148-152 (1993). |
C.S. Wright et al., "Structure of Subtilisin BPN'at 2.5 .ANG. Resolution", Nature, 221, pp. 235-242 (1969). |